par
John R. Fischer, Senior Reporter | January 02, 2019
Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon?
Another up-and-coming treatment expected to come from progress made in proton as well as radiation therapy is carbon heavy ion radiotherapy, as demonstrated earlier this year by Best Particle Therapy.
Ad Statistics
Times Displayed: 2147
Times Visited: 10 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
400 MeV ion Rapid Cycling Medical
Synchrotron in development
The division of TeamBest Companies
announced its plan in May to construct a Proton-to-Carbon Heavy Ion system for highly precise, conformal and hypofractionated radiation therapy. Composed of variable energy and heavy ion treatment technologies, the 400 MeV ion Rapid Cycling Medical Synchrotron (iRCMS) will offer a more advanced form of cancer treatment, compared to current options.
“Our technology is the most sophisticated and yet the simplest solution, providing the most precise, conformal and hypofractionated radiation therapy of five fractions, compared to the range of 30 to 40 fractions found in proton, X-ray, and gamma external-beam radiation therapies,” Krishnan Suthanthiran, founder and president of TeamBest Companies and the Best Cure Foundation, told HCB News at the time.
BPT plans to release its 400 MeV iRCMS in two to three years' time.
